Dans le cadre des douleurs neuropathiques localisées, les patchs de capsaïcine sont un traitement recommandé internationalement.
La capsaïcine, qui est un dérivé du piment, va activer dans la zone où elle est appliquée les récepteurs à la chaleur. Ces récepteurs sont reliés aux fibres qui conduisent le message douloureux et leur modulation entraine une désensibilisation de la zone. Peu à peu la douleur va diminuer et la zone réduire, voire disparaître.
Les poses de patchs se réalisent en hôpital de jour, en général tous les 2 mois tant que nécessaire, au Cabinet d’Algologie au sein de la Clinique Chénieux. Le médecin délimitera la zone à traiter puis vous serez pris en charge par l’équipe infirmière dédiée.
En sortant de votre soin, vous prenez un rendez-vous avec votre médecin algologue pour l’évaluation du traitement.
Contacter l’hôpital de jour du Cabinet d’Algolgie
lundi au vendredi de 09h00 à 16h30 au 05-55-45-46-07 ou hdj.algo@polyclinique-limoges.fr
Références scientifiques
1954841
{1954841:JAGVTRIL},{1954841:3ZIEXDI3},{1954841:ZUI9EILV},{1954841:6LJWG84Q}
1
chicago-fullnote-bibliography
50
date
128
http://cabinetdouleurlimoges.fr/wp-content/plugins/zotpress/
%7B%22status%22%3A%22success%22%2C%22updateneeded%22%3Afalse%2C%22instance%22%3Afalse%2C%22meta%22%3A%7B%22request_last%22%3A0%2C%22request_next%22%3A0%2C%22used_cache%22%3Atrue%7D%2C%22data%22%3A%5B%7B%22key%22%3A%22ZUI9EILV%22%2C%22library%22%3A%7B%22id%22%3A1954841%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Moisset%20et%20al.%22%2C%22parsedDate%22%3A%222020-04-07%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BMoisset%2C%20X.%2C%20D.%20Bouhassira%2C%20J.%20Avez%20Couturier%2C%20H.%20Alchaar%2C%20S.%20Conradi%2C%20M.%20H.%20Delmotte%2C%20M.%20Lanteri-Minet%2C%20et%20al.%20%26%23x201C%3BPharmacological%20and%20Non-Pharmacological%20Treatments%20for%20Neuropathic%20Pain%3A%20Systematic%20Review%20and%20French%20Recommendations.%26%23x201D%3B%20%26lt%3Bi%26gt%3BRevue%20Neurologique%26lt%3B%5C%2Fi%26gt%3B%2C%20April%207%2C%202020.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.neurol.2020.01.361%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.neurol.2020.01.361%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Pharmacological%20and%20non-pharmacological%20treatments%20for%20neuropathic%20pain%3A%20Systematic%20review%20and%20French%20recommendations%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22X.%22%2C%22lastName%22%3A%22Moisset%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22D.%22%2C%22lastName%22%3A%22Bouhassira%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22J.%22%2C%22lastName%22%3A%22Avez%20Couturier%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22H.%22%2C%22lastName%22%3A%22Alchaar%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22S.%22%2C%22lastName%22%3A%22Conradi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22M.%20H.%22%2C%22lastName%22%3A%22Delmotte%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22M.%22%2C%22lastName%22%3A%22Lanteri-Minet%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22J.%20P.%22%2C%22lastName%22%3A%22Lefaucheur%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22G.%22%2C%22lastName%22%3A%22Mick%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22V.%22%2C%22lastName%22%3A%22Piano%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22G.%22%2C%22lastName%22%3A%22Pickering%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22E.%22%2C%22lastName%22%3A%22Piquet%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22C.%22%2C%22lastName%22%3A%22Regis%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22E.%22%2C%22lastName%22%3A%22Salvat%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22N.%22%2C%22lastName%22%3A%22Attal%22%7D%5D%2C%22abstractNote%22%3A%22Neuropathic%20pain%20remains%20a%20significant%20unmet%20medical%20need.%20Several%20recommendations%20have%20recently%20been%20proposed%20concerning%20pharmacotherapy%2C%20neurostimulation%20techniques%20and%20interventional%20management%2C%20but%20no%20comprehensive%20guideline%20encompassing%20all%20these%20treatments%20has%20yet%20been%20issued.%20We%20performed%20a%20systematic%20review%20of%20pharmacotherapy%2C%20neurostimulation%2C%20surgery%2C%20psychotherapies%20and%20other%20types%20of%20therapy%20for%20peripheral%20or%20central%20neuropathic%20pain%2C%20based%20on%20studies%20published%20in%20peer-reviewed%20journals%20before%20January%202018.%20The%20main%20inclusion%20criteria%20were%20chronic%20neuropathic%20pain%20for%20at%20least%20three%20months%2C%20a%20randomized%20controlled%20methodology%2C%20at%20least%20three%20weeks%20of%20follow-up%2C%20at%20least%2010%20patients%20per%20group%2C%20and%20a%20double-blind%20design%20for%20drug%20therapy.%20Based%20on%20the%20GRADE%20system%2C%20we%20provide%20weak-to-strong%20recommendations%20for%20use%20and%20proposal%20as%20a%20first-line%20treatment%20for%20SNRIs%20%28duloxetine%20and%20venlafaxine%29%2C%20gabapentin%20and%20tricyclic%20antidepressants%20and%2C%20for%20topical%20lidocaine%20and%20transcutaneous%20electrical%20nerve%20stimulation%20specifically%20for%20peripheral%20neuropathic%20pain%3B%20a%20weak%20recommendation%20for%20use%20and%20proposal%20as%20a%20second-line%20treatment%20for%20pregabalin%2C%20tramadol%2C%20combination%20therapy%20%28antidepressant%20combined%20with%20gabapentinoids%29%2C%20and%20for%20high-concentration%20capsaicin%20patches%20and%20botulinum%20toxin%20A%20specifically%20for%20peripheral%20neuropathic%20pain%3B%20a%20weak%20recommendation%20for%20use%20and%20proposal%20as%20a%20third-line%20treatment%20for%20high-frequency%20rTMS%20of%20the%20motor%20cortex%2C%20spinal%20cord%20stimulation%20%28failed%20back%20surgery%20syndrome%20and%20painful%20diabetic%20polyneuropathy%29%20and%20strong%20opioids%20%28in%20the%20absence%20of%20an%20alternative%29.%20Psychotherapy%20%28cognitive%20behavioral%20therapy%20and%20mindfulness%29%20is%20recommended%20as%20a%20second-line%20therapy%2C%20as%20an%20add-on%20to%20other%20therapies.%20An%20algorithm%20encompassing%20all%20the%20recommended%20treatments%20is%20proposed.%22%2C%22date%22%3A%22April%207%2C%202020%22%2C%22language%22%3A%22en%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.neurol.2020.01.361%22%2C%22ISSN%22%3A%220035-3787%22%2C%22url%22%3A%22http%3A%5C%2F%5C%2Fwww.sciencedirect.com%5C%2Fscience%5C%2Farticle%5C%2Fpii%5C%2FS0035378720304720%22%2C%22collections%22%3A%5B%22T4BNQF6Q%22%5D%2C%22dateModified%22%3A%222020-04-21T11%3A47%3A06Z%22%7D%7D%2C%7B%22key%22%3A%22JAGVTRIL%22%2C%22library%22%3A%7B%22id%22%3A1954841%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Prudhomme%20et%20al.%22%2C%22parsedDate%22%3A%222020-02-01%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BPrudhomme%2C%20M.%2C%20A.%20Legras%2C%20C.%20Delorme%2C%20T.%20Lansaman%2C%20M.%20Lanteri-Minet%2C%20J.%20Medioni%2C%20M.%20Navez%2C%20et%20al.%20%26%23x201C%3BManagement%20of%20Neuropathic%20Pain%20Induced%20by%20Surgery%3A%20Review%20of%20the%20Literature%20by%20a%20Group%20of%20Experts%20Specialized%20in%20Pain%20Management%2C%20Anesthesia%20and%20Surgery.%26%23x201D%3B%20%26lt%3Bi%26gt%3BJournal%20of%20Visceral%20Surgery%26lt%3B%5C%2Fi%26gt%3B%20157%2C%20no.%201%20%28February%201%2C%202020%29%3A%2043%26%23x2013%3B52.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.jviscsurg.2019.09.004%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.jviscsurg.2019.09.004%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Management%20of%20neuropathic%20pain%20induced%20by%20surgery%3A%20Review%20of%20the%20literature%20by%20a%20group%20of%20experts%20specialized%20in%20pain%20management%2C%20anesthesia%20and%20surgery%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22M.%22%2C%22lastName%22%3A%22Prudhomme%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22A.%22%2C%22lastName%22%3A%22Legras%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22C.%22%2C%22lastName%22%3A%22Delorme%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22T.%22%2C%22lastName%22%3A%22Lansaman%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22M.%22%2C%22lastName%22%3A%22Lanteri-Minet%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22J.%22%2C%22lastName%22%3A%22Medioni%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22M.%22%2C%22lastName%22%3A%22Navez%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22S.%22%2C%22lastName%22%3A%22Perrot%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22G.%22%2C%22lastName%22%3A%22Pickering%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22A.%22%2C%22lastName%22%3A%22Serrie%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22E.%22%2C%22lastName%22%3A%22Viel%22%7D%5D%2C%22abstractNote%22%3A%22Chronic%20postsurgical%20neuropathic%20pain%20%28CPSNP%29%20is%20frequent.%20While%20prevalence%20varies%20considerably%20according%20to%20type%20of%20operation%20and%20means%20of%20evaluation%2C%20it%20can%20reach%2037%25%20following%20breast%20surgery.%20Identification%20of%20risk%20factors%20related%20to%20the%20procedure%20and%20to%20the%20patient%20and%20taking%20into%20account%20the%20development%20of%20new%2C%20minimally%20invasive%20surgical%20techniques%20is%20increasingly%20nerve-sparing%20and%20reduces%20the%20likelihood%20of%20injury.%20CPSNP%20diagnosis%20in%20daily%20practice%20is%20facilitated%20by%20simple%20and%20quickly%20usable%20tools%20such%20as%20the%20NP4%204-question%20test.%20Management%20is%20based%20on%20pharmacological%20%28analgesics%2C%20antiepileptics%2C%20antidepressants%2C%20local%20anesthetics%29%20and%20non-pharmacological%20%28kinesitherapy%2C%20neurostimulation%2C%20psychotherapy%29%20approaches.%20In%20light%20of%20the%20present%20review%20of%20the%20literature%2C%20the%20authors%2C%20who%20constitute%20an%20expert%20group%20specialized%20in%20pain%20management%2C%20anesthesia%20and%20surgery%2C%20express%20their%20support%20for%20topical%20treatments%20%28lidocaine%2C%20capsaicin%29%20in%20treatment%20of%20localized%20postsurgical%20neuropathic%20pain%20in%20adults.%22%2C%22date%22%3A%22February%201%2C%202020%22%2C%22language%22%3A%22en%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.jviscsurg.2019.09.004%22%2C%22ISSN%22%3A%221878-7886%22%2C%22url%22%3A%22http%3A%5C%2F%5C%2Fwww.sciencedirect.com%5C%2Fscience%5C%2Farticle%5C%2Fpii%5C%2FS1878788619301389%22%2C%22collections%22%3A%5B%22T4BNQF6Q%22%5D%2C%22dateModified%22%3A%222020-04-21T11%3A47%3A37Z%22%7D%7D%2C%7B%22key%22%3A%223ZIEXDI3%22%2C%22library%22%3A%7B%22id%22%3A1954841%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Perrot%20and%20Lant%5Cu00e9ri-Minet%22%2C%22parsedDate%22%3A%222019-07%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BPerrot%2C%20Serge%2C%20and%20Michel%20Lant%26%23xE9%3Bri-Minet.%20%26%23x201C%3BPatients%26%23x2019%3B%20Global%20Impression%20of%20Change%20in%20the%20Management%20of%20Peripheral%20Neuropathic%20Pain%3A%20Clinical%20Relevance%20and%20Correlations%20in%20Daily%20Practice.%26%23x201D%3B%20%26lt%3Bi%26gt%3BEuropean%20Journal%20of%20Pain%20%28London%2C%20England%29%26lt%3B%5C%2Fi%26gt%3B%2023%2C%20no.%206%20%28July%202019%29%3A%201117%26%23x2013%3B28.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1002%5C%2Fejp.1378%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1002%5C%2Fejp.1378%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Patients%27%20Global%20Impression%20of%20Change%20in%20the%20management%20of%20peripheral%20neuropathic%20pain%3A%20Clinical%20relevance%20and%20correlations%20in%20daily%20practice%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Serge%22%2C%22lastName%22%3A%22Perrot%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Michel%22%2C%22lastName%22%3A%22Lant%5Cu00e9ri-Minet%22%7D%5D%2C%22abstractNote%22%3A%22BACKGROUND%3A%20Patient-Reported%20Outcome%20%28PRO%29%20instruments%20have%20been%20developed%20to%20evaluate%20pain%20management%20in%20daily%20practice%3B%20the%20Patients%26%23039%3B%20Global%20Impression%20of%20Change%20%28PGIC%29%20is%20particularly%20recommended%20by%20the%20Initiative%20on%20Methods%2C%20Measurement%2C%20and%20Pain%20Assessment%20in%20Clinical%20Trials.%20The%20prospective%20non-interventional%20multicenter%20PRO-QURE%20study%20aimed%20at%20assessing%20correlations%20between%20PGIC%20and%20pain%20measurements%20and%20treatment%20effects%20in%20patients%20followed%20in%20French%20pain%20centres.%5CnMETHODS%3A%20Respectively%2C%20495%20and%20379%20patients%20with%20peripheral%20neuropathic%20pain%20initiating%20treatment%20with%20capsaicin%208%25%20cutaneous%20patch%28es%29%20%28female%2C%2062.6%25%3B%20mean%20age%2C%2054.0%5Cu00a0%5Cu00b1%5Cu00a014.8%5Cu00a0years%3B%20post-surgical%20or%20traumatic%20pain%2C%2052.7%25%3B%20mean%20pain%20duration%2C%2042.2%5Cu00a0%5Cu00b1%5Cu00a054.1%5Cu00a0months%3B%20DN4%20score%20%26gt%3B4%2C%2092.9%25%29%20completed%20the%20PGIC%20and%20several%20other%20PRO%20instruments%20before%20%28baseline%29%20and%203%5Cu00a0months%20%28M3%29%20after%20treatment%20application.%5CnRESULTS%3A%20At%20M3%2C%20improvement%20%28%26quot%3Bmuch%20improved%26quot%3B%20or%20%26quot%3Bvery%20much%20improved%26quot%3B%29%20was%20observed%20in%2023.0%25%20of%20patients%2C%20associated%20with%20decreases%20of%20-3.0%5Cu00a0%5Cu00b1%5Cu00a02.2%2C%20-2.5%5Cu00a0%5Cu00b1%5Cu00a02.4%2C%20and%20-23.1%5Cu00a0%5Cu00b1%5Cu00a019.7%20in%20BPI%20pain%20intensity%2C%20BPI%20pain%20interference%20and%20NPSI%20total%20scores%2C%20respectively.%20The%20highest%20Spearman%26%23039%3Bs%20rank%20correlation%20coefficients%20with%20PGIC%20were%20found%20for%20pain%20intensity%20%28BPI%3A%20r%5Cu00a0%3D%5Cu00a0-0.479%2C%20p%5Cu00a0%26lt%3B%5Cu00a00.001%29%2C%20satisfaction%20with%20current%20state%20%28Patient%20Acceptable%20Symptomatic%20State%3A%20r%5Cu00a0%3D%5Cu00a00.455%2C%20p%5Cu00a0%26lt%3B%5Cu00a00.001%29%2C%20and%20treatment%20effectiveness%20%28TSQM%3A%20r%5Cu00a0%3D%5Cu00a00.431%2C%20p%5Cu00a0%26lt%3B%5Cu00a00.001%29%3B%20correlation%20coefficients%20were%20lower%20for%20all%20NPSI%20scores%2C%20BPI%20pain%20interference%20score%2C%20HAD%20scores%20and%20EQ-5D-3L%20index.%5CnCONCLUSIONS%3A%20In%20daily%20clinical%20practice%2C%20significant%20improvement%20in%20peripheral%20neuropathic%20pain%2C%20as%20assessed%20by%20PGIC%20scores%2C%20significantly%20correlated%20with%20changes%20in%20well-established%20measures%20of%20pain%20intensity%2C%20pain%20interference%20with%20activities%20of%20daily%20living%2C%20mood%20and%20quality%20of%20life%2C%20confirming%20its%20clinical%20interest%20as%20PRO%20measure%20in%20real-world%20conditions.%5CnSIGNIFICANCE%3A%20Clinically%20important%20improvement%20in%20peripheral%20neuropathic%20pain%2C%20as%20assessed%20by%20PGIC%20scores%2C%20significantly%20correlated%20with%20well-established%20measures%20of%20pain%20intensity%2C%20pain%20interference%20in%20daily%20life%20and%20treatment%20efficacy.%20This%20result%2C%20associated%20with%20the%20ease%20of%20administration%20and%20scoring%2C%20encourages%20the%20widespread%20use%20of%20the%20PGIC%20in%20daily%20practice.%22%2C%22date%22%3A%22Jul%202019%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1002%5C%2Fejp.1378%22%2C%22ISSN%22%3A%221532-2149%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22T4BNQF6Q%22%5D%2C%22dateModified%22%3A%222020-04-21T19%3A23%3A55Z%22%7D%7D%2C%7B%22key%22%3A%226LJWG84Q%22%2C%22library%22%3A%7B%22id%22%3A1954841%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Martinez%20et%20al.%22%2C%22parsedDate%22%3A%222015-02-01%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BMartinez%2C%20Val%26%23xE9%3Bria%2C%20Patrick%20Assoune%2C%20Frederic%20Valadas%2C%20Thierry%20Delorme%2C%20and%20Elisabeth%20Collin.%20%26%23x201C%3BPlace%20du%20patch%20de%20capsa%26%23xEF%3Bcine%20%26%23xE0%3B%20haute%20concentration%20%288%26%23xA0%3B%25%29%20dans%20la%20strat%26%23xE9%3Bgie%20th%26%23xE9%3Brapeutique%20des%20douleurs%20neuropathiques%20p%26%23xE9%3Briph%26%23xE9%3Briques.%26%23x201D%3B%20%26lt%3Bi%26gt%3BDouleurs%26%23x202F%3B%3A%20Evaluation%20-%20Diagnostic%20-%20Traitement%26lt%3B%5C%2Fi%26gt%3B%2016%2C%20no.%201%20%28February%201%2C%202015%29%3A%2026%26%23x2013%3B31.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.douler.2014.12.005%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.douler.2014.12.005%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Place%20du%20patch%20de%20capsa%5Cu00efcine%20%5Cu00e0%20haute%20concentration%20%288%5Cu00a0%25%29%20dans%20la%20strat%5Cu00e9gie%20th%5Cu00e9rapeutique%20des%20douleurs%20neuropathiques%20p%5Cu00e9riph%5Cu00e9riques%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Val%5Cu00e9ria%22%2C%22lastName%22%3A%22Martinez%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Patrick%22%2C%22lastName%22%3A%22Assoune%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Frederic%22%2C%22lastName%22%3A%22Valadas%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Thierry%22%2C%22lastName%22%3A%22Delorme%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Elisabeth%22%2C%22lastName%22%3A%22Collin%22%7D%5D%2C%22abstractNote%22%3A%22R%5Cu00e9sum%5Cu00e9%5CnLes%20traitements%20topiques%20repr%5Cu00e9sentent%20une%20nouvelle%20alternative%20dans%20la%20prise%20en%20charge%20de%20la%20douleur%20neuropathique%20%28DN%29.%20Ils%20agissent%20de%20fa%5Cu00e7on%20cibl%5Cu00e9e%20sur%20la%20zone%20douloureuse%20r%5Cu00e9duisant%20ainsi%20le%20risque%20d%5Cu2019effets%20ind%5Cu00e9sirables%20syst%5Cu00e9miques%20et%20d%5Cu2019interactions%20m%5Cu00e9dicamenteuses.%20Qutenza%5Cu00ae%2C%20patch%20de%20capsa%5Cu00efcine%20%5Cu00e0%20forte%20concentration%20%288%5Cu00a0%25%29%20est%20indiqu%5Cu00e9%20dans%20le%20traitement%20des%20DN%20p%5Cu00e9riph%5Cu00e9riques%20chez%20l%5Cu2019adulte%20non%20diab%5Cu00e9tique.%20Ce%20traitement%20a%20obtenu%20une%20AMM%20en%202009%5Cu00a0sur%20la%20base%20d%5Cu2019essais%20cliniques%20dans%20les%20douleurs%20post-zost%5Cu00e9riennes%20et%20les%20neuropathies%20li%5Cu00e9es%20au%20VIH.%20La%20Commission%20de%20la%20transparence%20pr%5Cu00e9cise%20que%20Qutenza%5Cu00ae%20doit%20%5Cu00eatre%20r%5Cu00e9serv%5Cu00e9%20aux%20patients%20en%20%5Cu00e9chec%20aux%20traitements%20conventionnels.%20Dans%20les%20recommandations%20de%20prise%20en%20charge%20de%20la%20DN%20%5Cu00e9tablies%20en%202010%5Cu00a0par%20la%20SFETD%2C%20il%20apparaissait%20en%20tant%20que%20%5Cu00ab%5Cu00a0traitement%20%5Cu00e9mergent%5Cu00a0%5Cu00bb%20et%20sa%20place%20dans%20la%20strat%5Cu00e9gie%20th%5Cu00e9rapeutique%20n%5Cu2019%5Cu00e9tait%20pas%20encore%20clairement%20d%5Cu00e9finie.%20Depuis%20la%20litt%5Cu00e9rature%20s%5Cu2019est%20enrichie%20de%20nouvelles%20%5Cu00e9tudes%20et%20notre%20exp%5Cu00e9rience%20clinique%20a%20augment%5Cu00e9.%20Son%20positionnement%20doit%20%5Cu00eatre%20revu.%20Ainsi%2C%20la%20prescription%20des%20patchs%20de%20capsa%5Cu00efcine%20intervient%20en%20cas%20d%5Cu2019inefficacit%5Cu00e9%20des%20traitements%20de%20premi%5Cu00e8re%20intention.%20Ils%20peuvent%20%5Cu00eatre%20propos%5Cu00e9s%20seuls%20ou%20en%20association%20en%20cas%20d%5Cu2019%5Cu00e9chec%20ou%20d%5Cu2019efficacit%5Cu00e9%20partielle%20de%20traitements%20de%20premi%5Cu00e8re%20intention.%20Dans%20tous%20les%20cas%2C%20la%20prescription%20des%20patchs%20de%20capsa%5Cu00efcine%20doit%20%5Cu00eatre%20envisag%5Cu00e9e%20avant%20l%5Cu2019instauration%20des%20opio%5Cu00efdes%20forts%20dans%20les%20douleurs%20neuropathiques%20p%5Cu00e9riph%5Cu00e9riques.%5CnSummary%5CnTopical%20treatments%20represent%20new%20treatment%20option%20for%20the%20management%20of%20neuropathic%20pain%20%28NP%29.%20They%20have%20a%20specific%20action%20on%20the%20painful%20area%20which%20limits%20the%20risk%20of%20systemic%20adverse%20drug%20reactions%20and%20interaction%20with%20other%20medicinal%20product.%20Qutenza%2C%20high%20concentration%20%288%25%29%20capsaicin%20patch%2C%20is%20indicated%20for%20the%20treatment%20of%20peripheral%20NP%20in%20non-diabetic%20adults.%20This%20treatment%20has%20been%20approved%20in%202009%20on%20the%20basis%20of%20controlled%20clinical%20trials%20conducted%20in%20post-herpetic%20neuralgia%20and%20painful%20HIV%20associated%20neuropathy.%20The%20Transparency%20Committee%20specifies%20that%20Qutenza%20should%20be%20restricted%20to%20patients%20who%20have%20failed%20to%20respond%20to%20standard%20therapies%20for%20NP.%20Treatment%20recommendations%20for%20the%20management%20of%20NP%20established%20in%202010%20by%20the%20SFETD%20%28French%20chapter%20of%20IASP%29%2C%20presented%20Qutenza%20as%20an%20%5Cu201cemerging%5Cu201d%20drug%20but%20its%20place%20in%20the%20therapeutic%20strategy%20was%20not%20clearly%20defined.%20Since%2C%20new%20studies%20have%20been%20conducted%20and%20our%20clinical%20experience%20has%20increased%2C%20its%20place%20in%20the%20strategy%20should%20be%20reviewed.%20Hence%2C%20capsaicin%20patches%20prescription%20takes%20place%20in%20case%20of%20non-response%20to%20first%20line%20treatment.%20In%20case%20of%20failure%20or%20partial%20response%2C%20patches%20can%20be%20proposed%20alone%20or%20in%20combination.%20In%20every%20instance%2C%20the%20prescription%20of%20capsaicin%20patches%20should%20be%20considered%20before%20the%20use%20of%20strong%20opioids%20for%20peripheral%20neuropathic%20pain.%22%2C%22date%22%3A%22February%201%2C%202015%22%2C%22language%22%3A%22fr%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.douler.2014.12.005%22%2C%22ISSN%22%3A%221624-5687%22%2C%22url%22%3A%22http%3A%5C%2F%5C%2Fwww.sciencedirect.com%5C%2Fscience%5C%2Farticle%5C%2Fpii%5C%2FS1624568714002005%22%2C%22collections%22%3A%5B%22T4BNQF6Q%22%5D%2C%22dateModified%22%3A%222020-04-21T19%3A10%3A55Z%22%7D%7D%5D%7D
Moisset, X., D. Bouhassira, J. Avez Couturier, H. Alchaar, S. Conradi, M. H. Delmotte, M. Lanteri-Minet, et al. “Pharmacological and Non-Pharmacological Treatments for Neuropathic Pain: Systematic Review and French Recommendations.” Revue Neurologique, April 7, 2020. https://doi.org/10.1016/j.neurol.2020.01.361.
Prudhomme, M., A. Legras, C. Delorme, T. Lansaman, M. Lanteri-Minet, J. Medioni, M. Navez, et al. “Management of Neuropathic Pain Induced by Surgery: Review of the Literature by a Group of Experts Specialized in Pain Management, Anesthesia and Surgery.” Journal of Visceral Surgery 157, no. 1 (February 1, 2020): 43–52. https://doi.org/10.1016/j.jviscsurg.2019.09.004.
Perrot, Serge, and Michel Lantéri-Minet. “Patients’ Global Impression of Change in the Management of Peripheral Neuropathic Pain: Clinical Relevance and Correlations in Daily Practice.” European Journal of Pain (London, England) 23, no. 6 (July 2019): 1117–28. https://doi.org/10.1002/ejp.1378.
Martinez, Valéria, Patrick Assoune, Frederic Valadas, Thierry Delorme, and Elisabeth Collin. “Place du patch de capsaïcine à haute concentration (8 %) dans la stratégie thérapeutique des douleurs neuropathiques périphériques.” Douleurs : Evaluation - Diagnostic - Traitement 16, no. 1 (February 1, 2015): 26–31. https://doi.org/10.1016/j.douler.2014.12.005.